Regulation and metabolic functions of mTORC1 and mTORC2

A Szwed, E Kim, E Jacinto - Physiological reviews, 2021 - journals.physiology.org
Cells metabolize nutrients for biosynthetic and bioenergetic needs to fuel growth and
proliferation. The uptake of nutrients from the environment and their intracellular metabolism …

Metabolomics for investigating physiological and pathophysiological processes

DS Wishart - Physiological reviews, 2019 - journals.physiology.org
Metabolomics uses advanced analytical chemistry techniques to enable the high-throughput
characterization of metabolites from cells, organs, tissues, or biofluids. The rapid growth in …

Signaling pathways in brain tumors and therapeutic interventions

S Li, C Wang, J Chen, Y Lan, W Zhang… - … and Targeted Therapy, 2023 - nature.com
Brain tumors, although rare, contribute to distinct mortality and morbidity at all ages.
Although there are few therapeutic options for brain tumors, enhanced biological …

The role of ubiquitination and deubiquitination in cancer metabolism

T Sun, Z Liu, Q Yang - Molecular cancer, 2020 - Springer
Metabolic reprogramming, including enhanced biosynthesis of macromolecules, altered
energy metabolism, and maintenance of redox homeostasis, is considered a hallmark of …

Navigating metabolic pathways to enhance antitumour immunity and immunotherapy

X Li, M Wenes, P Romero, SCC Huang… - Nature reviews Clinical …, 2019 - nature.com
The development of immunotherapies over the past decade has resulted in a paradigm shift
in the treatment of cancer. However, the majority of patients do not benefit from …

Altered cellular metabolism in gliomas—An emerging landscape of actionable co-dependency targets

J Bi, S Chowdhry, S Wu, W Zhang, K Masui… - Nature Reviews …, 2020 - nature.com
Altered cellular metabolism is a hallmark of gliomas. Propelled by a set of recent
technological advances, new insights into the molecular mechanisms underlying glioma …

A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations

Y Zhang, PKS Ng, M Kucherlapati, F Chen, Y Liu… - Cancer cell, 2017 - cell.com
Molecular alterations involving the PI3K/AKT/mTOR pathway (including mutation, copy
number, protein, or RNA) were examined across 11,219 human cancers representing 32 …

Coupling Krebs cycle metabolites to signalling in immunity and cancer

DG Ryan, MP Murphy, C Frezza, HA Prag… - Nature …, 2019 - nature.com
Metabolic reprogramming has become a key focus for both immunologists and cancer
biologists, with exciting advances providing new insights into the mechanisms underlying …

Mutant IDH inhibits IFNγ–TET2 signaling to promote immunoevasion and tumor maintenance in cholangiocarcinoma

MJ Wu, L Shi, J Dubrot, J Merritt, V Vijay, TY Wei… - Cancer …, 2022 - aacrjournals.org
Abstract Isocitrate dehydrogenase 1 mutations (mIDH1) are common in
cholangiocarcinoma.(R)-2-hydroxyglutarate generated by the mIDH1 enzyme inhibits …

2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …